• Department of Thoracic Surgery,Medical College of Yangzhou University,Yangzhou 225001,Jiangsu,P. R. China;
Export PDF Favorites Scan Get Citation

Objective To isolate,culture and expand bone marrow mesenchymal stem cells (MSCs) in vitro,induce MSCs to differentiate directionally towards chondrocytes,and provide experimental basis for clinical application of MSCs and construction of tissue engineering tracheal cartilage. Methods Cultured MSCs were isolated from bone marrow of Sprague-Dawley rats,purified using adherence separation,and identified by flow cytometry analysis. Transforming growth factor β1 (TGF-β1)and insulin-like growth factor 1 (IGF-1) were used as main induction factors to induce MSCs to differentiate directionally towards chondrocytes. The expression of collagen typeⅡwas evaluated by immunocytochemical staining 21 days after induction. Light microscope and electron microscope were used to observe tiny and ultrastructural changes of the cells before and after induction. Results The expression of collagen typeⅡwas positive by immunocytochemical staining 21 days after induction. MSCs were fusiform before induction under light microscope and electron microscope. After induction,the cells became larger,polygon,star-shaped or triangular. Transmission electron microscope showed that the cells had abundant organelles,larger nuclei and more nucleoli after induction. Conclusion Abundant organelles,larger nuclei and more nucleoli are the ultrastructure changes of chondrocytes differentiated from MSCs,indicating that the cells are active in differentiation and metabolism.

Citation: TAN Rongbang,SHI Hongcan.. In Vitro Induction of Directional Differentiation of Bone Marrow Mesenchymal Stem Cells towards Chondrocytes. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2013, 20(3): 325-328. doi: 10.7507/1007-4848.20130097 Copy

  • Previous Article

    Pseudomonas Aeruginosa Injection in Treatment for Lymph Leakage after Neck Dissection in Thyroid Carcinoma
  • Next Article

    Pseudomonas Aeruginosa Injection in Treatment for Lymph Leakage after Neck Dissection in Thyroid Carcinoma